Gilead uses HealthVerity data to find liver-protective treatment
Antiretroviral therapy (ART) has transformed outcomes for people living with HIV, especially those...
Antiretroviral therapy (ART) has transformed outcomes for people living with HIV, especially those...
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs)...
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
The HealthVerity Marketplace webinar wrapped up with a clear message. The Marketplace model is not...
GLP-1 Trends: Ozempic and Semaglutide drive a 587% spike in prescriptions Prescriptions for GLP-1...
Prostate cancer is the most common cancer among men, aside from skin cancer, and is known for being...
Traditional data aggregators are not enough The pharmaceutical industry is hitting a wall. Data...
Open claims and closed payer claims data are essential for understanding the status and activities...
Antiretroviral therapy (ART) has transformed outcomes for people living with HIV, especially those also managing chronic hepatitis B virus (HBV) coinfection. But not all ART regimens have the same long-term impact on liver health, particularly in thi...